{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:40:18Z","timestamp":1792669218730,"version":"4.5.0"},"reference-count":29,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":173,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"publisher","award":["81800140"],"award-info":[{"award-number":["81800140"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"publisher","award":["82000144"],"award-info":[{"award-number":["82000144"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.csbj.2022.06.051","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T01:46:04Z","timestamp":1656294364000},"page":"3304-3312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comprehensive analysis of the novel omicron receptor AXL in cancers"],"prefix":"10.34133","volume":"20","author":[{"given":"Wei-Na","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Hematology, Guangzhou Women and Children's Medical Center, Guangzhou, 510623, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou 500020, China"},{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Fei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Guangzhou Women and Children's Medical Center, Guangzhou, 510623, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Guangzhou Women and Children's Medical Center, Guangzhou, 510623, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hua","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Guangzhou Women and Children's Medical Center, Guangzhou, 510623, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jun","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou 500020, China"},{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"e_1_3_5_3_2","article-title":"Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant","author":"Zhang N.N.","year":"2022","unstructured":"Zhang N.N. et al: Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant. Cell Res 2022; .","journal-title":"Cell Res"},{"key":"e_1_3_5_4_2","article-title":"Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection","author":"Hall V.","year":"2022","unstructured":"Hall V. et al: Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection. N Engl J Med 2022; .","journal-title":"N Engl J Med"},{"key":"e_1_3_5_5_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang W.","year":"2020","unstructured":"Liang W. et al: Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21: 335.","journal-title":"Lancet Oncol"},{"key":"e_1_3_5_6_2","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.7150\/ijbs.51234","article-title":"Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients","volume":"16","author":"Dai Y.J.","year":"2020","unstructured":"Dai Y.J. et al: Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients. Int J Biol Sci 2020; 16: 3028.","journal-title":"Int J Biol Sci"},{"key":"e_1_3_5_7_2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.21037\/atm.2020.03.61","article-title":"A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection","volume":"8","author":"Dai Y.J.","year":"2020","unstructured":"Dai Y.J. et al: A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection. Ann Transl Med 2020; 8: 481.","journal-title":"Ann Transl Med"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-00460-y"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.06.034"},{"key":"e_1_3_5_10_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41392-021-00653-w","article-title":"Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy","volume":"6","author":"Zhang Q.","year":"2021","unstructured":"Zhang Q. et al: Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal Transduct Target Ther 2021; 6: 233.","journal-title":"Signal Transduct Target Ther"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1378"},{"key":"e_1_3_5_12_2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030466","article-title":"AXL receptor tyrosine kinase as a promising therapeutic target directing multiple aspects of cancer progression and metastasis","volume":"14","author":"Goyette M.A.","year":"2022","unstructured":"Goyette M.A. and Cote J.F.: AXL receptor tyrosine kinase as a promising therapeutic target directing multiple aspects of cancer progression and metastasis. Cancers (Basel) 2022; 14.","journal-title":"Cancers (Basel)"},{"key":"e_1_3_5_13_2","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S1470-2045(20)30311-9","article-title":"Poor clinical outcomes for patients with cancer during the COVID-19 pandemic","volume":"21","author":"Tang L.V.","year":"2020","unstructured":"Tang L.V. and Hu Y.: Poor clinical outcomes for patients with cancer during the COVID-19 pandemic. Lancet Oncol 2020; 21: 862.","journal-title":"Lancet Oncol"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa407"},{"key":"e_1_3_5_15_2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12288-021-01417-w","article-title":"Efficacy and safety of convalescent plasma for COVID-19: A systematic review and meta-analysis","volume":"37","author":"Prasad M.","year":"2021","unstructured":"Prasad M., Seth T. and Elavarasi A.: Efficacy and safety of convalescent plasma for COVID-19: A systematic review and meta-analysis. Indian J Hematol Blood Transfus 2021; 37: 347.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3847"},{"key":"e_1_3_5_17_2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.immuni.2022.01.009","article-title":"Immune sensing of microbial metabolites: Action at the tumor","volume":"55","author":"Frankel T.L.","year":"2022","unstructured":"Frankel T.L. and Pasca di Magliano M.: Immune sensing of microbial metabolites: Action at the tumor. Immunity 2022; 55: 192.","journal-title":"Immunity"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.07.002"},{"key":"e_1_3_5_19_2","article-title":"Identification of neoantigens for individualized therapeutic cancer vaccines","author":"Lang F.","year":"2022","unstructured":"Lang F. et al: Identification of neoantigens for individualized therapeutic cancer vaccines. Nat Rev Drug Discov 2022; .","journal-title":"Nat Rev Drug Discov"},{"key":"e_1_3_5_20_2","article-title":"Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis","author":"Hart W.S.","year":"2022","unstructured":"Hart W.S. et al: Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis. Lancet Infect Dis 2022; .","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_5_21_2","doi-asserted-by":"crossref","first-page":"e1010171","DOI":"10.1371\/journal.ppat.1010171","article-title":"Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells","volume":"18","author":"Grau-Exposito J.","year":"2022","unstructured":"Grau-Exposito J. et al: Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells. PLoS Pathog 2022; 18: e1010171.","journal-title":"PLoS Pathog"},{"key":"e_1_3_5_22_2","article-title":"Prediction analysis of porcine AXL protein as a potential receptor for SARS-CoV-2","author":"Zeng C.","year":"2021","unstructured":"Zeng C. et al: Prediction analysis of porcine AXL protein as a potential receptor for SARS-CoV-2. J Infect 2021; .","journal-title":"J Infect"},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2478\/acph-2022-0024","article-title":"AXL inhibitors selected by molecular docking: Option for reducing SARS-CoV-2 entry into cells %J Acta Pharmaceutica","volume":"72","author":"Galindo-Hern\u00e1ndez O.","year":"2022","unstructured":"Galindo-Hern\u00e1ndez O. and Vique-S\u00e1nchez J.L.: AXL inhibitors selected by molecular docking: Option for reducing SARS-CoV-2 entry into cells %J Acta Pharmaceutica. Acta Pharmaceutica 2022; 72: 329.","journal-title":"Acta Pharmaceutica"},{"key":"e_1_3_5_24_2","article-title":"Identifying enhancers of innate immune signaling as broad-spectrum antivirals active against emerging viruses","author":"Maarifi G.","year":"2022","unstructured":"Maarifi G. et al: Identifying enhancers of innate immune signaling as broad-spectrum antivirals active against emerging viruses. Cell Chem Biol 2022; .","journal-title":"Cell Chem Biol"},{"key":"e_1_3_5_25_2","article-title":"Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6\/AXL signalling axis","author":"Bellomo G.","year":"2022","unstructured":"Bellomo G. et al: Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6\/AXL signalling axis. Gut 2022; .","journal-title":"Gut"},{"key":"e_1_3_5_26_2","article-title":"Bemcentinib and gilteritinib inhibit cell growth and impair the endo-lysosomal and autophagy systems in an AXL-independent manner","author":"Zdzalik-Bielecka D.","year":"2021","unstructured":"Zdzalik-Bielecka D. et al: Bemcentinib and gilteritinib inhibit cell growth and impair the endo-lysosomal and autophagy systems in an AXL-independent manner. Mol Cancer Res 2021; .","journal-title":"Mol Cancer Res"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3114"},{"key":"e_1_3_5_28_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1158\/1535-7163.MCT-21-0293","article-title":"AXL inhibitor TP-0903 reduces metastasis and therapy resistance in pancreatic cancer","volume":"21","author":"Zhang Y.","year":"2022","unstructured":"Zhang Y. et al: AXL inhibitor TP-0903 reduces metastasis and therapy resistance in pancreatic cancer. Mol Cancer Ther 2022; 21: 38.","journal-title":"Mol Cancer Ther"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2020.04.001"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0972"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037022002653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037022002653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2022.06.051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T13:01:45Z","timestamp":1779022905000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2022.06.051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":29,"alternative-id":["10.1016\/j.csbj.2022.06.051"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2022.06.051","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive analysis of the novel omicron receptor AXL in cancers","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2022.06.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}